Literature DB >> 4590198

The effect of trimethoprim on macromolecular synthesis in Escherichia coli.

R J Smith, J E Midgley.   

Abstract

In trimethoprim-inhibited RC(str) strains of Escherichia coli, the expression of the RC control of stable RNA synthesis arose primarily from a decrease in the intracellular concentrations of glycine and methionine, and not from inhibition of the initiation of new protein chains. In non-supplemented cultures, experiments with rifampicin showed that the immediate response to the addition of trimethoprim was a rapid decrease in the rate of initiation of RNA chains. This was followed after a few minutes by a sufficiently large fall in the rate of endogenous synthesis of nucleotide bases to cause a decrease in the rate of RNA chain polymerization. Inhibition of RNA chain initiation was thus overridden by an accumulation of DNA-dependent RNA polymerases upon the cistrons. RC(rel) strains also accumulated polymerases upon the DNA in similar circumstances, but did not suffer the initial effects on chain initiation. If purines were supplied before adding trimethoprim, RC(str) strains polymerized RNA chains at normal rates, but initiation rates were permanently decreased. In either situation, an increased% of the RNA formed was mRNA. However, in RC(rel) strains supplemented with bases, trimethoprim did not affect either the rate of initiation of new chains or their rates of polymerization or the relative rates of synthesis of stable RNA and mRNA. Protein synthesis was also severely inhibited by trimethoprim. Though the addition of glycine and methionine to base-supplemented, trimethoprim-inhibited RC(str) strains did not apparently affect the decreased rate of protein synthesis, RNA accumulation resumed at its normal rate. Thus, the inhibition of protein chain initiation had no effect on the rate of RNA accumulation in either RC(str) or RC(rel) bacteria. The RC control does not express itself through inhibitions of protein synthesis at this level.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4590198      PMCID: PMC1165948          DOI: 10.1042/bj1360225a

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Inhibitor binding analysis of dihydrofolate reductases from various species.

Authors:  J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

Review 2.  Inhibition of folate biosynthesis and function as a basis for chemotherapy.

Authors:  G H Hitchings; J J Burchall
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1965

3.  Scattered arrangement of the bacterial ribosomal cistrons.

Authors:  I Purdom; J O Bishop; M L Birnstiel
Journal:  Nature       Date:  1970-07-18       Impact factor: 49.962

4.  The control of ribonucleic acid synthesis in Escherichia coli. 3. The functional relationship between purine ribonucleoside triphosphate pool sizes and the rate of ribonucleic acid accumulation.

Authors:  J Gallant; B Harada
Journal:  J Biol Chem       Date:  1969-06-25       Impact factor: 5.157

5.  On the relation between ribonucleic acid synthesis and peptide chain initiation in E. coli.

Authors:  A Y Shih; J Eisenstadt; P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

6.  Regulation of nucleoside triphosphate pools in Escherichia coli.

Authors:  G Edlin; J Neuhard
Journal:  J Mol Biol       Date:  1967-03-14       Impact factor: 5.469

7.  Formylmethionyl-tRNA dependence of amino acid incorporation in extracts of trimethoprim-treated Escherichia coli.

Authors:  J Eisenstadt; P Lengyel
Journal:  Science       Date:  1966-10-28       Impact factor: 47.728

8.  Nucleoside triphosphate pools and the regulation of RNA synthesis in E. coli.

Authors:  G Edlin; G S Stent
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

9.  Characterization of rapidly labelled ribonucleic acid in Escherichia coli by deoxyribonucleic acid-ribonucleic acid hybridization.

Authors:  G H Pigott; J E Midgley
Journal:  Biochem J       Date:  1968-11       Impact factor: 3.857

10.  A new approach to the analysis of hybridization of bacterial nucleic acids. Analysis of the ribosomal ribonucleic acids of Bacillus subtilis.

Authors:  R J Avery; J E Midgley
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

View more
  7 in total

1.  In vivo regulatory responses of four Escherichia coli operons which encode leucyl-tRNAs.

Authors:  K B Rowley; R M Elford; I Roberts; W M Holmes
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

2.  Turnover as a control of ribonucleic acid accumulation in bacteria undergoing stepdown.

Authors:  J E Midgley
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

3.  The control of ribonucleic acid synthesis in bacteria. Fluctuations in messenger ribonucleic acid synthesis in cultures recovering from amino acid starvation.

Authors:  J E Midgley; R J Smith
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

4.  The effect of trimethoprim on macromolecular synthesis in Escherichia coli. Ribosome maturation in RCstr and RCrel strains.

Authors:  J E Midgley; R J Smith
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857

5.  Early changes in the messenger ribonucleic acid concentration of amino acid-starved cells of Escherichia coli are not dependent on the state of the rel gene.

Authors:  J E Midgley; R J Smith
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

6.  The effect of trimethoprim on macromolecular synthesis in Escherichia coli. Regulation of ribonucleic acid synthesis by 'Magic Spot' nucleotides.

Authors:  R J Smith; J E Midgley
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857

7.  The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim.

Authors:  Dipen P Sangurdekar; Zhigang Zhang; Arkady B Khodursky
Journal:  BMC Genomics       Date:  2011-11-28       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.